Hovione has announced the addition of a new MG2 Tekna capsule filler for filling DPI capsules at the company’s Loures, Portugal facilities. The MG2 Tekna machine, which has a capacity of up to 110,000 capsules/hour with 100% fill weight check, can be used for filling highly potent compounds.
The company said in the announcement, “This investment reinforces Hovione’s Services portfolio in inhalation product development capabilities, which include proprietary particle engineering technologies as well as formulation and capsule filling capacity to support from development to commercial scale projects,” noting that the facility already has MG2 Flexlab and Mettler-Toledo Quantos machines used to fill capsules for Phase 1 and Phase 2 clinical trials and has increased spray drying capacity for highly potent compounds.
Hovione VP R&D Filipe Gaspar commented, “We are excited to announce this new integrated offering, all at the same site where our scientists work together in the interface between particle engineering and final drug product for the benefit of an optimal product performance. This will allow us to support our customer’s inhalation projects at all scales and contribute to accelerate drug development and manufacturing timelines.”
VP Marketing and Sales Frédéric Kahn added, “These investments are driven by significant client demand, since the market is looking for integrated inhalation product development solutions that reduce program risk and complexity. Hovione has all the ingredients for an outstanding partnership starting from clinical programs and into commercial supply.”
Read the Hovione press release.
